Patents by Inventor David WEISBROD

David WEISBROD has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11996593
    Abstract: An electrochemical cell that oxidizes a solution provides a continuous and stable supply of an oxidizing ion solution to a fixture or vessel used for the purposes of decontaminating metal and metal alloys. The electrochemical cell includes an anode compartment that oxidizes the solution in nitric acid or methane sulfonic acid at a rate equal to or greater than a rate of reduction, or generates the oxidizing ions prior to use in a batch. The electrochemical cell is part of a larger system that facilitates online measurement system which measures the oxidizing ion solution and the dissolved PuO2, UO2, AmO2, other radionuclides, or other contaminates in real-time. Solution decontamination system removes the dissolved PuO2/UO2/AmO2, other radionuclides, or other contaminates from the oxidizing ion solution, real time acoustic monitoring of the thickness of the surface being contaminated, and automation of a delivery system facilitates flow between surface and electrochemical cell.
    Type: Grant
    Filed: May 28, 2021
    Date of Patent: May 28, 2024
    Assignee: TRIAD NATIONAL SECURITY, LLC
    Inventors: Benjamin Karmiol, Sean Peter Walsh, David Anthony Tyler Rodriguez, Jared Tyler Stritzinger, Steven Douglas McKee, Kirk Weisbrod, Jeremy Jacob Monroe, Gabriel Andrade, Quinn McCulloch, Janelle Droessler, Alp Tugrul Findikoglu, Taeho Ju
  • Publication number: 20220047557
    Abstract: Methods of inducing bradycardia (slowing a heart rate) in a subject in need thereof, treating a medical condition in which inducing bradycardia (slowing a heart rate) is desirable or beneficial in a subject in need thereof and/or treating a medical condition associated with cardiac arrhythmia, are provided. The methods are effected by blocking SK4 channel in SAN cell of the subject and/or by administering to the subject a therapeutically effective amount of a blocker of an SK4 channel. A method of identifying candidate compounds for treating an arrhythmic cardiac disorder, by identifying compounds that reduce a pacing rate of the SAN cells is also provided.
    Type: Application
    Filed: October 28, 2021
    Publication date: February 17, 2022
    Applicant: Ramot at Tel-Aviv University Ltd.
    Inventors: David WEISBROD, Bernard ATTALI, Asher PERETZ
  • Patent number: 11166940
    Abstract: Methods of inducing bradycardia (slowing a heart rate) in a subject in need thereof, treating a medical condition in which inducing bradycardia (slowing a heart rate) is desirable or beneficial in a subject in need thereof and/or treating a medical condition associated with cardiac arrhythmia, are provided. The methods are effected by blocking SK4 channel in SAN cell of the subject and/or by administering to the subject a therapeutically effective amount of a blocker of an SK4 channel. A method of identifying candidate compounds for treating an arrhythmic cardiac disorder, by identifying compounds that reduce a pacing rate of the SAN cells is also provided.
    Type: Grant
    Filed: December 21, 2017
    Date of Patent: November 9, 2021
    Assignee: Ramot at Tel-Aviv University Ltd.
    Inventors: David Weisbrod, Bernard Attali, Asher Peretz
  • Publication number: 20180177764
    Abstract: Methods of inducing bradycardia (slowing a heart rate) in a subject in need thereof, treating a medical condition in which inducing bradycardia (slowing a heart rate) is desirable or beneficial in a subject in need thereof and/or treating a medical condition associated with cardiac arrhythmia, are provided. The methods are effected by blocking SK4 channel in SAN cell of the subject and/or by administering to the subject a therapeutically effective amount of a blocker of an SK4 channel. A method of identifying candidate compounds for treating an arrhythmic cardiac disorder, by identifying compounds that reduce a pacing rate of the SAN cells is also provided.
    Type: Application
    Filed: December 21, 2017
    Publication date: June 28, 2018
    Inventors: David WEISBROD, Bernard ATTALI